Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor.
about
Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivoSuppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNAHOXB7 constitutively activates basic fibroblast growth factor in melanomasColony-stimulating factor 1 promotes progression of mammary tumors to malignancyTreatment with diphenyl-pyrazole compound anle138b/c reveals that α-synuclein protects melanoma cells from autophagic cell death.Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasisIn vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides.Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.Skin as a living coloring book: how epithelial cells create patterns of pigmentation.Loss-of-function fibroblast growth factor receptor-2 mutations in melanomaFunctional analysis and molecular targeting of aurora kinases a and B in advanced melanoma.Turbo FISH: a method for rapid single molecule RNA FISH.Expression analysis and molecular targeting of cyclin-dependent kinases in advanced melanoma.The broad-spectrum receptor tyrosine kinase inhibitor dovitinib suppresses growth of BRAF-mutant melanoma cells in combination with other signaling pathway inhibitors.Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin.Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma.Human melanoma progression in skin reconstructs : biological significance of bFGF.Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Malignant melanoma as a paradigmGrowth and invasion of human melanomas in human skin grafted to immunodeficient miceSuramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane.Unusual growth characteristics of human melanoma xenografts in the nude mouse: a model for desmoplasia, dormancy and progressionFibroblast growth factor receptors as therapeutic targets in human melanoma: synergism with BRAF inhibition.Expression of basic fibroblast growth factor and its receptor in human pancreatic carcinomas.Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma.Expression of transforming growth factor alpha (TGF-alpha) gene in mouse embryonic development.A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase.Macroscopic spectral imaging and gene expression analysis of the early stages of melanoma.Prothymosin alpha antisense oligomers inhibit myeloma cell division.Anti-sense transforming growth factor alpha oligonucleotides inhibit autocrine stimulated proliferation of a colon carcinoma cell lineHOX Gene Aberrant Expression in Skin Melanoma: A Review.Involvement of basic fibroblast growth factor in suramin-induced inhibition of V79/AP4 fibroblast cell proliferation.Suppression of tumor growth and angiogenesis in vivo by a truncated form of 24-kd fibroblast growth factor (FGF)-2.K-252a and staurosporine selectively block autophosphorylation of neurotrophin receptors and neurotrophin-mediated responses.The proliferative and morphologic responses of a colon carcinoma cell line (LIM 1215) require the production of two autocrine factors.Differential expression of basic fibroblast growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. Implications for tumor progression.The DEAD/DEAH box helicase, DDX11, is essential for the survival of advanced melanomas.Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression.A vaccine targeting basic fibroblast growth factor elicits a protective immune response against murine melanoma.
P2860
Q24564477-07E069B2-4187-44F9-955B-4E2EDF993876Q24646731-6EC53640-49F4-4930-A1EE-343AA7D63EF5Q24648665-C39E43AF-468A-423F-AEC0-C8AF7F7975DDQ29614312-DAED457F-8975-4E98-ACAB-0A2ED4427DA7Q33847750-54B99D91-1A74-49FB-8181-4E1AFB38B99EQ33894102-6A71CCA4-4746-4C0B-81C2-726B0988F74DQ34047054-438C03AE-2E7E-4962-BD57-4CA12B017303Q34155667-C3B7B9F9-B377-4C15-B236-5731DF6222DDQ34415873-99AE710B-5C4D-40D9-AA90-B2CD1AA11C79Q34520671-A31E4D40-8B4E-4198-A4BB-6B657B5FF474Q34972522-74DD9636-069A-4107-B373-DEC18B67B21DQ34997457-8995CA60-AF15-498D-A9AB-A594A47C0B44Q35002325-0F2DBCEE-DE27-4923-BC2B-3224508A9D3EQ35597799-B8937315-657B-4955-97FE-C5736F19934FQ35746395-695BF40B-BA00-4A4F-A7A4-EBA66820E557Q35747496-2FF1B454-398D-47F9-BAE7-7A28DF903C86Q35793439-B57E5AA9-AC73-4680-8417-8E4A4F2D190CQ35804856-647A3F88-71E3-4C1B-A6A5-EEE7E053D892Q35833134-0C4C0FFA-0F06-482D-9338-6D3BBDB14F3BQ35977856-DB1F7C36-84CB-4402-94CE-53649FCD8EFFQ35993558-99D34E00-357F-4085-949F-6F3E0C4D42D1Q36059811-74F5975D-7D8E-4573-B8C9-4FDE9DF221C3Q36081619-E023294D-5187-4555-8C89-2E49160C0583Q36134259-6D6CD791-05CE-42C9-9475-916F7A9BD908Q36267468-8ABEC403-69F5-4EC6-A9D4-18A6B867C3C4Q36361511-33F895F3-466D-43B2-9A4C-FD82F78BDB75Q36438580-3647B1A8-F87A-466E-96FA-D571819EAEBAQ37363976-06D066CF-F8B2-49E0-834B-BA9E02FCC917Q37374782-0BACEBFA-F35C-4706-9297-CFA08A0031C7Q38054730-3D9B47A0-110F-46DB-825D-0CB5B31EB84CQ38318941-4C284171-5E17-4F93-98B0-5A7ECAB8D4B1Q38730211-26EA5A9E-FA9A-4009-B51B-47033529E541Q40241179-F7D0BF0A-B6CE-48CB-9F8D-38E9DC79A504Q41670362-7D158E0B-483F-4BD6-BD20-78ED55886C6CQ42140194-AB963C20-91C6-48FB-B5E8-2EB0EEC1744EQ42282611-9A24C1ED-1F4B-402F-910D-0BB77EA5671DQ42794629-31265876-A2A8-4D76-BA36-88BE466125E5Q48511578-71715572-79AF-45E4-88EA-C0B045B6F3AB
P2860
Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Proliferation of human maligna ...... asic fibroblast growth factor.
@en
type
label
Proliferation of human maligna ...... asic fibroblast growth factor.
@en
prefLabel
Proliferation of human maligna ...... asic fibroblast growth factor.
@en
P2093
P2860
P1433
P1476
Proliferation of human maligna ...... asic fibroblast growth factor.
@en
P2093
P2860
P304
P407
P577
1989-12-01T00:00:00Z